Max Rubner Award

The project plan should clearly state the identified problem or need, as well as how the proposed concept intends to address it. It should also demonstrate the potential benefits the idea offers to Charité as a whole, as well as to its staff, patients, or students.

The Max Rubner Award is an innovation award that recognizes novel or innovative approaches that distinguish themselves from existing processes or products. Special attention should be given to this aspect, along with a clear specification of any required resources and a timeframe for implementation.

In addition, applicants are asked to identify any risks associated with their project and to describe how the project’s sustainability will be ensured. This could involve integration into Charité’s ongoing operations, in which case the source of continued funding must be specified. Sustainability may also be achieved through founding a company or by establishing new structures that Charité could adopt in the long term.

By submitting an application, the applicant confirms that they have read and understood Stiftung Charité’s grant conditions (Bewilligungsgrundsätze) as well as all relevant program information related to their application. The applicant accepts these documents as the legally binding basis for any funding granted for their project. Additionally, the applicant acknowledges Stiftung Charité’s standards for the implementation of funded projects and the applicable data protection policies (Datenschutzhinweise).

Project proposals deemed fundamentally eligible for funding are first forwarded to an internal steering committee, which provides an initial professional assessment. During this process, the proposals are also examined to determine whether alternative internal funding sources within Charité may be appropriate. Based on these assessments, a jury deliberates on all submitted proposals and makes a final decision regarding which projects will receive the award.

Jury Members include:

• Dr. Jörg Appelhans, Chair, Stiftung Charité
• Katharina Hochfeld, Fraunhofer Institute for Industrial Engineering | IAO
• Dr. Markus Müschenich, Eternity.Health
• Prof. Thoralf Niendorf, Max Delbrück Center for Molecular Medicine
• Prof. Dr. Brigitte Oetker, Institute for Arts and Media Management, HfMT Hamburg
• Dr. Magnus Rüde, Board Office, Charité – Universitätsmedizin Berlin
• Dr. Isabel N. Schellinger, CEO and Founder, Angiolutions

Winners will be informed promptly and will receive an invitation to Charité’s annual spring reception, during which the award ceremony takes place.